Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
BioPlus Acquisition Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$10.80 |
52 Week High | US$11.68 |
52 Week Low | US$10.05 |
Beta | 0 |
1 Month Change | -0.046% |
3 Month Change | 1.46% |
1 Year Change | 7.31% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | n/a |
Recent News & Updates
Recent updates
Shareholder Returns
BIOS | US Capital Markets | US Market | |
---|---|---|---|
7D | -0.2% | 1.7% | 0.4% |
1Y | 7.3% | 32.8% | 28.8% |
Return vs Industry: BIOS matched the US Capital Markets industry which returned 8% over the past year.
Return vs Market: BIOS underperformed the US Market which returned 14.1% over the past year.
Price Volatility
BIOS volatility | |
---|---|
BIOS Average Weekly Movement | 0.5% |
Capital Markets Industry Average Movement | 3.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BIOS has not had significant price volatility in the past 3 months.
Volatility Over Time: BIOS's weekly volatility (0%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | R. Ross Haghighat | https://bioplusspac.com |
BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
BioPlus Acquisition Corp. Fundamentals Summary
BIOS fundamental statistics | |
---|---|
Market cap | US$209.07m |
Earnings (TTM) | US$5.79m |
Revenue (TTM) | n/a |
36.1x
P/E Ratio0.0x
P/S RatioIs BIOS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIOS income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | -US$5.79m |
Earnings | US$5.79m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.30 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -39.6% |
How did BIOS perform over the long term?
See historical performance and comparison